Oric Pharmaceuticals, Inc. (ORIC) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the ORIC Pharmaceuticals fourth quarter and full year 2021 financial results and operational update call. At this time, all participants are on a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. Please be advised that today's conference is being recorded, and if you require any further assistance, please press star 0. I want to hand the conference over to speaker today, Dominic Piccitelli, Chief Financial Officer. Please go ahead. Good afternoon, and welcome to the Oreck Pharmaceuticals' fourth quarter and full year 2021 financial results and operational update call. Following the market close today, we filed our Form 10-K and issued a press release with our financial results for the fourth quarter and full year ended December 31st, 2021. You may find these documents posted on the investor page of orcfarmer.com. We have pre-recorded a portion of our prepared remarks, after which we will host a live Q&A session, so please bear with us if we have any technical difficulties. Before we begin, starting on slide two, during this conference call, we will be making forward-looking statements. OREC's actual results may differ materially from those expressed in or indicated by such forward-looking statements. For a description of risk factors associated with investing in OREC, please refer to our recent filing with the Securities Exchange Commission. OREC specifically disclaims any obligation to update any forward-looking statements except as required by law. Now turning to slide three, I'll briefly walk you through our agenda and introduce our speakers. During today's call, we'll primarily focu...